WG
MDGL icon

Winton Group’s Madrigal Pharmaceuticals MDGL Stock Holding History

Winton Group’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-11,535
Closed -$1.31M – 1557
2020
Q2 		$1.31M Buy
11,535
+6,164
+115% +$606K 0.03% 850
2020
Q1 		$359K Sell
5,371
-810
-13% -$67.5K 0.01% 1122
2019
Q4 		$563K Buy
+6,181
New +$599K 0.01% 1209
2019
Q1 		– Sell
-5,187
Closed -$585K – 1137
2018
Q4 		$585K Buy
5,187
+1,971
+61% +$305K 0.01% 443
2018
Q3 		$689K Buy
3,216
+1,742
+118% +$437K 0.01% 512
2018
Q2 		$412K Sell
1,474
-1,097
-43% -$193K 0.01% 710
2018
Q1 		$300K Buy
+2,571
New +$317K 0.01% 978

Other funds holding MDGL

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Winton Group's MDGL Position: Q3 2020 in Review

Winton Group sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2020, closing a stake of 11,535 shares — an estimated $1.31M sold.

Winton Group first reported a position in MDGL in Q1 2018 and held it in 7 quarters. The position peaked at $1.31M in Q2 2020. 124 funds tracked by Wall St. Rank hold MDGL as of Q3 2020.

  • Winton Group reported no remaining Madrigal Pharmaceuticals position as of Q3 2020 after selling out during the quarter.
  • Winton Group sold 11,535 Madrigal Pharmaceuticals shares in Q3 2020, an estimated $1.31M.
  • Winton Group first reported a position in Madrigal Pharmaceuticals in Q1 2018 and held it in 7 quarters.
  • Winton Group's Madrigal Pharmaceuticals position peaked at $1.31M in Q2 2020.
  • 124 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2020.

Based on Winton Group's 13F filing for Q3 2020, filed 30 Oct 2020.